Bio-thera Solutions

This study is testing a new combination of two drugs, BAT8008 and BAT1308, for people with advanced solid tumors that have not responded to standard treatments. The main goals are to find the safest and most effective dose and to see if the combination can help shrink or control …

This study aimed to test a new targeted drug called BAT8006 for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to standard platinum-based chemotherapy. The two-part trial planned to first find a safe and effective dose, then …

This study is testing whether an investigational drug called BAT4406F can safely prevent relapses in adults with neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that attacks the nerves in the eyes and spinal cord. Participants are randomly assigned to re…

This study is testing an experimental drug called BAT6026 for adults with moderate to severe eczema that hasn't responded well to standard creams and ointments. Researchers are comparing different doses against a placebo to see which works best and is safest. The main goal is to …